企業プロフィール
AtriCure 株価・ニュース・カタリスト
- ティッカー:
- ATRC
- 取引所:
- NASDAQ
- セクター:
- MedTech
- 所在地:
- United States
株価パフォーマンス
44.77 USD (+1.06%)
終値
最終更新: 2026年8月17日
1.31B USD
時価総額
株価変動の要因
As of Aug 17, 2026, ATRC closed up 1.06% at $44.77. No new same-company headline was identified in the current news window.
企業概要
Atrial Fibrillation Surgery
AtriCure develops medical devices and procedures for the surgical treatment of atrial fibrillation. Its products are used by cardiac surgeons to create controlled lesions that interrupt abnormal electrical pathways and restore a more regular heart rhythm.
Ablation Technologies
The Isolator Synergy Ablation System is FDA approved for persistent atrial fibrillation and anchors AtriCure’s surgical ablation portfolio. The company also offers the Hybrid AF Therapy, a minimally invasive approach for patients with long-standing persistent atrial fibrillation.
Adjacent Surgical Markets
AtriCure’s broader portfolio includes left atrial appendage management and post-operative pain-management products. These complementary technologies allow the company to serve multiple needs within cardiac and thoracic surgery using a common physician and hospital customer base.
今後のカタリスト
- AtriCure's catalysts are AF ablation adoption, left-atrial appendage management, and continued procedure growth in cardiac surgery. The company improves when its installed physician base keeps converting into repeatable use.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。